Cargando…

Inhibition of the fibroblast growth factor receptor (FGFR) pathway: the current landscape and barriers to clinical application

The fibroblast growth factor/fibroblast growth factor receptor (FGF/FGFR) is a tyrosine kinase signaling pathway that has a fundamental role in many biologic processes including embryonic development, tissue regeneration, and angiogenesis. Increasing evidence indicates that this pathway plays a crit...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chae, Young Kwang, Ranganath, Keerthi, Hammerman, Peter S., Vaklavas, Christos, Mohindra, Nisha, Kalyan, Aparna, Matsangou, Maria, Costa, Ricardo, Carneiro, Benedito, Villaflor, Victoria M., Cristofanilli, Massimo, Giles, Francis J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2016
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5362545/ https://www.ncbi.nlm.nih.gov/pubmed/28030802 http://dx.doi.org/10.18632/oncotarget.14109

Ejemplares similares

Concordance between genomic alterations assessed by next-generation sequencing in tumor tissue or circulating cell-free DNA
por: Chae, Young Kwang, et al.
Publicado: (2016)

FGFR3-TACC3 fusion in solid tumors: mini review
por: Costa, Ricardo, et al.
Publicado: (2016)

Genomic landscape of DNA repair genes in cancer
por: Chae, Young Kwang, et al.
Publicado: (2016)

Toxicity profile of approved anti-PD-1 monoclonal antibodies in solid tumors: a systematic review and meta-analysis of randomized clinical trials
por: Costa, Ricardo, et al.
Publicado: (2016)

Posterior reversible encephalopathy syndrome and takotsubo cardiomyopathy associated with lenvatinib therapy for thyroid cancer: a case report and review
por: Chae, Young Kwang, et al.
Publicado: (2018)

Adenoid cystic carcinoma: current therapy and potential therapeutic advances based on genomic profiling
por: Chae, Young Kwang, et al.
Publicado: (2015)

Developmental therapeutics for inflammatory breast cancer: Biology and translational directions
por: Costa, Ricardo, et al.
Publicado: (2016)

Challenges and future of biomarker tests in the era of precision oncology: Can we rely on immunohistochemistry (IHC) or fluorescence in situ hybridization (FISH) to select the optimal patients for matched therapy?
por: Chae, Young Kwang, et al.
Publicado: (2017)

Repurposing metformin for cancer treatment: current clinical studies
por: Chae, Young Kwang, et al.
Publicado: (2016)

A comprehensive review of heregulins, HER3, and HER4 as potential therapeutic targets in cancer
por: Mota, Jose Mauricio, et al.
Publicado: (2017)

The role of EGFR mutations in predicting recurrence in early and locally advanced lung adenocarcinoma following definitive therapy
por: Galvez, Carlos, et al.
Publicado: (2020)

FGFR3–TACC3: A novel gene fusion in cervical cancer
por: Carneiro, Benedito A., et al.
Publicado: (2015)

The Landscape of Targeted Therapies in TNBC
por: Vagia, Elena, et al.
Publicado: (2020)

Pseudoprogression in microsatellite instability-high colorectal cancer during treatment with combination T cell mediated immunotherapy: a case report and literature review
por: Chae, Young Kwang, et al.
Publicado: (2017)

The Association between EGFR and cMET Expression and Phosphorylation and Its Prognostic Implication in Patients with Breast Cancer
por: Chae, Young Kwang, et al.
Publicado: (2016)

Resistance to allosteric SHP2 inhibition in FGFR-driven cancers through rapid feedback activation of FGFR
por: Lu, Hengyu, et al.
Publicado: (2020)

A Rare Case of Glioblastoma Multiforme with Osseous Metastases
por: Costa, Rubens Barros, et al.
Publicado: (2017)

Ligand associated ERBB2/3 activation confers acquired resistance to FGFR inhibition in FGFR3 dependent cancer cells
por: Wang, Jun, et al.
Publicado: (2014)

Overexpression of adhesion molecules and barrier molecules is associated with differential infiltration of immune cells in non-small cell lung cancer
por: Chae, Young Kwang, et al.
Publicado: (2018)

Novel mutation detection of fibroblast growth factor receptor 1 (FGFR1) gene, FGFR2IIIa, FGFR2IIIb, FGFR2IIIc, FGFR3, FGFR4 gene for craniosynostosis: A prospective study in Asian Indian patient
por: Barik, Mayadhar, et al.
Publicado: (2015)

LGG-20. LANDSCAPE OF FGFR ALTERATIONS IN PEDIATRIC AND AYA GLIOMAS
por: Nobre, Liana, et al.
Publicado: (2023)

Fibroblast Growth Factor Receptor (FGFR) Inhibitors in Urothelial Cancer
por: Garje, Rohan, et al.
Publicado: (2020)

Negative Regulation of FGFR (Fibroblast Growth Factor Receptor) Signaling
por: Szybowska, Patrycja, et al.
Publicado: (2021)

Targeting FGFR in non-small cell lung cancer: implications from the landscape of clinically actionable aberrations of FGFR kinases
por: Zhou, Zhen, et al.
Publicado: (2021)

Clinical features, diagnostic challenges, and management strategies in checkpoint inhibitor-related pneumonitis
por: Chuzi, Sarah, et al.
Publicado: (2017)

Landscape of FGF/FGFR Alterations in 12,372 Chinese Cancer Patients
por: Zuo, Wei, et al.
Publicado: (2020)

Targeting the Fibroblast Growth Factor Receptor (FGFR) Family in Lung Cancer
por: Pacini, Laura, et al.
Publicado: (2021)

Expression of basic fibroblast growth factor, FGFR1 and FGFR2 in normal and malignant human breast, and comparison with other normal tissues.
por: Luqmani, Y. A., et al.
Publicado: (1992)

Fibroblast Growth Factor Receptor (FGFR) Signaling in GIST and Soft Tissue Sarcomas
por: Napolitano, Andrea, et al.
Publicado: (2021)

Inhibitor-Sensitive FGFR1 Amplification in Human Non-Small Cell Lung Cancer
por: Dutt, Amit, et al.
Publicado: (2011)

Differential Fibroblast Growth Factor 8 (FGF8)-Mediated Autoregulation of Its Cognate Receptors, Fgfr1 and Fgfr3, in Neuronal Cell Lines
por: Mott, Natasha N., et al.
Publicado: (2010)

Landscape of activating cancer mutations in FGFR kinases and their differential responses to inhibitors in clinical use
por: Patani, Harshnira, et al.
Publicado: (2016)

Genetic and epigenetic landscape of IDH-wildtype glioblastomas with FGFR3-TACC3 fusions
por: Mata, Douglas A., et al.
Publicado: (2020)

Fibroblast Growth Factor Receptor 2 (FGFR2) Mutation Related Syndromic Craniosynostosis
por: Azoury, Saïd C., et al.
Publicado: (2017)

Role of Fibroblast Growth Factor Receptor 2 (FGFR2) in Corneal Stromal Thinning
por: Joseph, Roy, et al.
Publicado: (2023)

FGFR2‐Altered Gastroesophageal Adenocarcinomas Are an Uncommon Clinicopathologic Entity with a Distinct Genomic Landscape
por: Klempner, Samuel J., et al.
Publicado: (2019)

Translational Dysregulation in Cancer: Molecular Insights and Potential Clinical Applications in Biomarker Development
por: Vaklavas, Christos, et al.
Publicado: (2017)

Hallmarks and Determinants of Oncogenic Translation Revealed by Ribosome Profiling in Models of Breast Cancer()
por: Vaklavas, Christos, et al.
Publicado: (2020)

Toward improved models of human cancer
por: Welm, Bryan E., et al.
Publicado: (2021)

Fibroblast growth factor receptor 3 (FGFR3) aberrations in muscle-invasive urothelial carcinoma
por: Kim, Young Saing, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_5bqghs9jsbkungpbomn22n5gah